Shape Therapeutics has signed a deal potentially exceeding $3 billion with pharma giant Roche to support…
dcorriganAugust 25, 2021
Immune cells have many jobs to do: Some identify infected cells and eliminate them. Others…
dcorriganAugust 24, 2021
Aptevo Therapeutics Inc., a clinical-stage biotechnology company focused on developing novel immuno-oncology therapeutics based on…
dcorriganAugust 18, 2021
HDT Bio Corp., a developer of immunotherapies for oncology and infectious diseases, announced today an…
dcorriganAugust 17, 2021
Evotec SE announced the opening of the company’s late-stage clinical and commercial biologics cGMP manufacturing…
dcorriganAugust 17, 2021
GentiBio is developing engineered regulatory T cells (Tregs) to build a better immune system and…
dcorriganAugust 16, 2021
In the race to develop new and better vaccines and boosters to block COVID-19, scientists…
dcorriganAugust 13, 2021
Curebase, a company committed to democratizing access to clinical studies, and Adaptive Biotechnologies Corp. (Nasdaq: ADPT),…
dcorriganAugust 12, 2021
Eliem Therapeutics joined the ranks of publicly traded companies from Washington state, pricing 6.4 million shares…
dcorriganAugust 11, 2021
